NYSE:STVN • IT0005452658
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for STEVANATO GROUP SPA (STVN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-12-02 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-07 | UBS | Maintains | Neutral -> Neutral |
| 2024-12-13 | Wolfe Research | Initiate | Outperform |
| 2024-12-13 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-07 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-04-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-03-25 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-11-01 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-01 | Jefferies | Downgrade | Buy -> Hold |
| 2023-09-26 | Stephens & Co. | Initiate | Overweight |
| 2023-09-19 | CJS Securities | Initiate | Market Outperform |
| 2023-08-30 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-08-24 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-07-31 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-07-31 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-07-17 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-06-26 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-06-20 | Morgan Stanley | Reiterate | Overweight |
| 2023-06-16 | B of A Securities | Maintains | Buy |
| 2023-06-12 | Morgan Stanley | Reiterate | Overweight |
| 2023-05-05 | Keybanc | Maintains | Overweight |
| 2023-05-05 | Wells Fargo | Maintains | Overweight |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 983.7M 16.57% | 1.085B 10.33% | 1.104B 1.72% | 1.197B 8.42% | 1.308B 9.27% | 1.439B 10.02% | 1.61B 11.88% | 1.658B 2.98% | 2.566B 54.76% | |
| EBITDA YoY % growth | 255.5M 16.67% | 291.5M 14.09% | 261.51M -10.29% | 296.58M 13.41% | 347.66M 17.22% | 412.4M 18.62% | 486.13M 17.88% | 517.68M 6.49% | N/A | |
| EBIT YoY % growth | 190.7M 17.28% | 213.02M 11.70% | 180.858M -15.10% | 204.28M 12.95% | 243.43M 19.16% | 296.74M 21.90% | 350.81M 18.22% | 373.49M 6.47% | 667.62M 78.75% | |
| Operating Margin | 19.39% | 19.63% | 16.38% | 17.07% | 18.61% | 20.62% | 21.79% | 22.53% | 26.02% | |
| EPS YoY % growth | 0.55 16.21% | 0.58 5.45% | 0.48 -17.24% | 0.54 10.49% | 0.65 21.74% | 0.81 25.55% | 0.98 20.77% | 1.10 12.12% | N/A |
All data in EUR
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.12 15.26% | 0.15 32.20% | 0.17 22.09% | 0.22 21.78% | 0.15 30.68% | 0.18 23.92% | 0.21 23.13% | 0.26 20.59% |
| Revenue Q2Q % growth | 280.24M 9.21% | 312.56M 11.63% | 337.36M 11.27% | 383.95M 10.84% | 307.37M 9.68% | 343.39M 9.86% | 376.59M 11.63% | 423.16M 10.21% |
| EBITDA Q2Q % growth | 68.178M 18.46% | 79.982M -6.63% | 91.57M -23.88% | 109.73M 17.62% | 80.363M 17.87% | 91.787M 14.76% | 107.71M 17.63% | 126.97M 15.71% |
| EBIT Q2Q % growth | 43.598M 18.06% | 54.382M 25.11% | 64.247M 14.07% | 82.232M 22.03% | 50.929M 16.81% | 63.485M 16.74% | 76.347M 18.83% | 94.432M 14.84% |
All data in EUR
17 analysts have analysed STVN and the average price target is 28.76 USD. This implies a price increase of 79.34% is expected in the next year compared to the current price of 16.035.
The consensus EPS estimate for the next earnings of STEVANATO GROUP SPA (STVN) is 0.12 USD and the consensus revenue estimate is 280.24M USD.
The number of analysts covering STEVANATO GROUP SPA (STVN) is 17.